Chemours CO DEF 14A proxy statements

Chemours is urging shareholders to vote in favor of Proposal 4, which requires an 80% approval, before the upcoming Annual Meeting on April 22nd to allow shareholders more influence over the company's future.

The Chemours Company is actively soliciting shareholders to vote on Proposal 4, an amendment to the Certificate of Incorporation, before the Annual Meeting of Shareholders on April 22, 2025.

The Chemours Company is urging shareholders to vote in favor of Proposal 4, which seeks to amend the company's Certificate of Incorporation to allow for amendments to be approved by a simple majority rather than a supermajority.

Chemours is urging shareholders to vote on several key proposals, including one to amend the Certificate of Incorporation to allow for majority voting on amendments to the Certificate and Bylaws.

The Chemours Company issued a supplement to its definitive proxy statement to correct an error in the reported beneficial ownership information of its directors, nominees, and executive officers.

Chemours outlines its refreshed 'Pathway to Thrive' strategy and welcomes new board members to drive long-term growth and shareholder value.

Chemours is committed to increasing ethnic and racial diversity on its board by the 2025 annual meeting and is seeking shareholder support for its director nominees at the upcoming 2024 meeting.

The Chemours Company will hold its virtual annual meeting of shareholders on May 21, 2024, to vote on the election of directors, executive compensation, and the ratification of PricewaterhouseCoopers LLP as the company's independent auditor.

Chemours is holding its annual shareholder meeting on May 21, 2024, following a period of leadership changes and an internal review.